21103-33-3
21103-33-3 structure
- Name: 4-[4-(2-METHOXY-PHENYL)-PIPERAZIN-1-YL]-BUTYLAMINE
- Chemical Name: 4-[4-(2-methoxyphenyl)piperazin-1-yl]butan-1-amine
- CAS Number: 21103-33-3
- Molecular Formula: C15H25N3O
- Molecular Weight: 263.37800
- Create Date: 2018-12-25 15:44:43
- Modify Date: 2024-01-05 16:30:19
| Name | 4-[4-(2-methoxyphenyl)piperazin-1-yl]butan-1-amine |
|---|---|
| Synonyms |
4-(4-(2-methoxyphenyl)piperazin-1-yl)but-1-ylamine
4-[4-(2-METHOXY-PHENYL)-PIPERAZIN-1-YL]-BUTYLAMINE N-(4-aminobutyl)-N'-(2-methoxyphenyl)piperazine 4-(4-(2-Methoxyphenyl)piperazin-1-yl)butan-1-amine 4-[4-(2-methoxyphenyl)-1-piperazinyl]butylamine 1-(4-Aminobutyl)-4-(2-methoxyphenyl)piperazine 1-(4-amino-1-butyl)-4-(2-methoxyphenyl)piperazine 4-<(2-methoxyphenyl)piperazin-1-yl>-butanamine 4-[4-(2-Methoxyphenyl)-1-Piperazinyl]-1-Butanamine |
| Density | 1.049g/cm3 |
|---|---|
| Boiling Point | 405.501ºC at 760 mmHg |
| Molecular Formula | C15H25N3O |
| Molecular Weight | 263.37800 |
| Flash Point | 199.04ºC |
| Exact Mass | 263.20000 |
| PSA | 41.73000 |
| LogP | 2.25930 |
| Vapour Pressure | 0mmHg at 25°C |
| Index of Refraction | 1.541 |
| Symbol |
GHS05 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H314 |
| Precautionary Statements | P280-P305 + P351 + P338-P310 |
| RIDADR | UN 2735PSN1 8 / PGII |
| HS Code | 2933599090 |
|
~90%
21103-33-3 |
| Literature: Hackling, Anneke; Ghosh, Robin; Perachon, Sylvie; Mann, Andre; Hoeltje, Hans-Dieter; Wermuth, Camille G.; Schwartz, Jean-Charles; Sippl, Wolfgang; Sokoloff, Pierre; Stark, Holger Journal of Medicinal Chemistry, 2003 , vol. 46, # 18 p. 3883 - 3899 |
|
~97%
21103-33-3 |
| Literature: Skultety, Marika; Huebner, Harald; Loeber, Stefan; Gmeiner, Peter Journal of Medicinal Chemistry, 2010 , vol. 53, # 19 p. 7219 - 7228 |
|
~%
21103-33-3 |
| Literature: Hackling, Anneke; Ghosh, Robin; Perachon, Sylvie; Mann, Andre; Hoeltje, Hans-Dieter; Wermuth, Camille G.; Schwartz, Jean-Charles; Sippl, Wolfgang; Sokoloff, Pierre; Stark, Holger Journal of Medicinal Chemistry, 2003 , vol. 46, # 18 p. 3883 - 3899 |
|
~%
21103-33-3 |
| Literature: Chu, Wenhua; Tu, Zhude; McElveen, Elizabeth; Xu, Jinbin; Taylor, Michelle; Luedtke, Robert R.; MacH, Robert H. Bioorganic and Medicinal Chemistry, 2005 , vol. 13, # 1 p. 77 - 87 |
|
~%
21103-33-3 |
| Literature: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) Patent: EP1683790 A1, 2006 ; Location in patent: Page/Page column 11 ; EP 1683790 A1 |
|
~%
21103-33-3 |
| Literature: Neurogen Corporation Patent: US5703237 A1, 1997 ; US 5703237 A |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |